Sign in
Taking people in United StatesNo phase

Identifying Biomarkers Related to Opioid Use and Pain Response Following Traumatic Injury and Surgery

Key facts

Who runs it
University of California, San Diego
Where
La Jolla, United StatesSee the site
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
15 Jul 2026
Expected to end
Jun 2027
Type of study
Observational, 2 groups
Record updated
17 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients 18 years of age or older
  • Patients admitted for traumatic injury at Hillcrest or Jacobs Medical Center or patients who will undergo the orthopedic (e.g., joint, spine), abdominal, breast, vascular (e.g., amputation), or thoracic surgery

Who cannot take part

  • Patients with a prior history of opioid use disorder or dependence
  • Patients with an inability to independently provide informed consent to participate in the study due to lack of capacity. This lack of capacity can be from either a chronic/continuous condition (i.e. dementia), or can be temporary (i.e. clear signs of intoxication at the time of the visit (not alert or oriented, slurring words [and confirmed not to be baseline], unsteady gait [and confirmed not to be baseline], or appears impaired based on clinical judgement by PI/Co-I))
  • Pregnant women
  • Prisoners

Where in United States

  • University of California San DiegoLa Jolla, United StatesContact: Rodney A GabrielTaking people

About the trial

What the trial wants to find out

The mechanisms leading to opioid tolerance or dependence are not well understood and there are currently no biomarkers for predicting who is at risk for development of OUD. The purpose of this project is to support the feasibility of detecting a miRNA bio-behavioral signature of opioid misuse risk that will demonstrate improved predictive precision compared to current tools such as polygenic risk scores (PRS). Specifically, the study will address key goals of the Wellcome Leap program to develop scalable measures assessing individual addiction susceptibility and quantifying addiction risk and progression during prescription drug use. The study will utilize behavioral, genomics, and bioinformatics pipelines to characterize opioid-induced miRNA expression dynamics among trauma and surgical patients prescribed opioids at discharge. Based on results from this study, the research will develop a high-throughput screening assay to predict risk for opioid use disorder (OUD). The hypothesis is that miRNAs will serve as powerful bio-signatures for predicting long-term clinical outcomes in patients treated with opioids for pain management following trauma injury and/or surgery.

The 2 groups in the trial

  • Persistent Opioid Use Cohort

    Patients who develop persistent opioid use after surgery (defined as any ongoing opioid use \>3 months after admission for trauma injury)

  • Non-persistent Opioid Use Cohort

    Patients who do not develop persistent opioid use after surgery (defined as no ongoing opioid ≥ 3 months after surgery)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
17 July 2026